• National Institute of Biomedical Imaging and Bioengineering (NIBIB) Perspective on the National Academies “State of the Science in Nuclear Medicine” Study, William Heetderks, M.D., Associate Director for Extramural Science Programs, NIBIB, NIH

  • Presentation to NAS Committee on “State of the Science in Nuclear Medicine,” Michael Welch, Ph.D., Professor of Radiology, Washington University School of Medicine, on behalf of the Society of Nuclear Medicine

  • Society of Radiopharmaceutical Sciences, William Eckelman, Ph.D., Adjunct Professor of Radiology, University of California at San Diego, on behalf of the Society of Radiopharmaceutical Sciences

  • State of the Science in Nuclear Medicine: IEEE Perspective, William Moses, Ph.D., Senior Staff Scientist in the Life Sciences Division at Lawrence Berkeley National Laboratory, on behalf of the IEEE Nuclear & Plasma Sciences Society

  • Issues Affecting the Future of Nuclear Medicine, Roy Brown, Senior Director, Federal Affairs, Council on Radionuclides and Radiopharmaceuticals

  • Perspectives from the Society of Molecular Imaging, Thomas Budinger, M.D., Ph.D., Professor of Radiology, University of California at San Francisco, on behalf of the Society of Molecular Imaging

  • State of the Science in Nuclear Medicine: A Physician-Scientist’s Perspective, Richard Wahl, M.D., Henry N. Wagner, Jr., Professor of Nuclear Medicine, Johns Hopkins University, on behalf of the Academy of Radiology Research

A.2
SECOND MEETING, AUGUST 24–25, 2006, WASHINGTON, D.C.

The objective of the second meeting was to gather information on the state of the science in radiopharmaceuticals and issues surrounding isotope availability to the nuclear medicine community (charges 1 and 3 of the statement of task). The following is the list of topics and speakers who presented during the open session:

  • NCI’s Current and Future Commitment to Translational Research: an Interim Report of the Translational Research Working Group, Ernest Hawk, M.D., M.P.H., Director of the Office of Centers, Training, & Resources in the Office of the Director, NCI, NIH

  • Radiopharmaceutical Chemistry: Future Needs and Directions, Michael Welch, Ph.D., Professor of Radiology, Molecular Biology and Pharmacology, and Biomedical Engineering, and Co-Director of the Division of Radiological Sciences, Washington University Medical School



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement